FR – Tratamiento intralesional del cáncer cutáneo no melanoma con 5-fluorouracilo

Background and objective Topical and intralesional (IL) treatments may be considered the first-line therapy in patients with hidradenitis suppurativa (HS); however, the evidence supporting their use is limited. The aim of our review is to […]